Health assessment of gasoline and fuel oxygenate vapors: Neurotoxicity evaluation

Regulatory Toxicology and Pharmacology

Volumn 70, Issue 2, 2014, Pages S35-S42

  O'Callaghan, James P ^a   Daughtrey, Wayne C ^b   Clark, Charles R ^c   Schreiner, Ceinwen A ^d   White, Russell ^e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EXXONMOBIL UPSTREAM RESEARCH COMPANY   (United States)

^c Phillips 66 Co   (United States)

^d C and C Consulting in Toxicology   (United States)

^e AMERICAN PETROLEUM INSTITUTE   (United States)

Author keywords

Astrogliosis; Diisopropyl ether; Ethanol; Ethyl t butyl ether; Gasoline vapor condensates; Glial fibrillary acidic protein (GFAP); Methyl tertiary butyl ether; Neurotoxicity; T Amyl methyl ether; T Butyl alcohol

Indexed keywords

ALCOHOL; DIISOPROPYL ETHER; EOSIN; ETHYL TERT BUTYL ETHER; FUEL; GASOLINE; GASOLINE VAPOR CONDENSATE; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMATOXYLIN; TERT AMYL METHYL ETHER; TERT BUTYL ALCOHOL; TERT BUTYL METHYL ETHER; UNCLASSIFIED DRUG; AIR POLLUTANT;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BEHAVIOR CHANGE; BRAIN CORTEX; BRAIN LEVEL; BRAIN STEM; BRAIN WEIGHT; CEREBELLUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; EXPOSURE; FEMALE; FUNCTIONAL OBSERVATION BATTERY; HAZARD ASSESSMENT; HIPPOCAMPUS; HISTOPATHOLOGY; HYPOPHYSIS; HYPOTHALAMUS; MALE; MOTOR ACTIVITY; NERVOUS SYSTEM PARAMETERS; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OLFACTORY BULB; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; STAINING; THALAMUS; VAPOR; AIR POLLUTANT; ANIMAL; BRAIN; DRUG EFFECTS; INHALATION; NEUROTOXICITY SYNDROMES; PATHOLOGY; RISK ASSESSMENT; SPRAGUE DAWLEY RAT; TOXICITY;

AIR POLLUTANTS; ANIMALS; BRAIN; FEMALE; GASOLINE; INHALATION; MALE; MOTOR ACTIVITY; NEUROTOXICITY SYNDROMES; RATS; RATS, SPRAGUE-DAWLEY; RISK ASSESSMENT;

EID: 84908284378     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2014.05.002     Document Type: Article

References (28)

1. Agresti A. A survey of models for repeated ordered categorical response data. Stat. Med. 1989, 8:1209-1224.
2. Balaban C.D., O'Callaghan J.P., Billingsley M.L. Trimethyl-tin-induced neuronal damage in the rat brain: comparative studies using silver degeneration stains, immunocytochemistry and immunoassay for neuronotypic and gliotypic proteins. Neuroscience 1988, 26:337-361.
3. Balaban C.D. The use of selective silver degebeation stains in neurotoxicology: Lessions from studies of selective neurotoxicants. The Vulnerable Brain and Environmental Risks, Vol 1. Malnutrition and Hazard Assessment 1992, 223-238. Plenum Press, New York. R.L. Issacson, K.F. Jensen (Eds.).
4. Benson J.M., Gigliotti A.P., March T.H., Barr E.B., Tibbetts B.M., Skipper B.J., Clark C.R., Twerdok L. Chronic carcinogenicity study of gasoline vapor condensate (GVC) and GVC containing methyl tertiary-butyl ether in F344 rats. J. Toxicol. Environ. Health 2011, 74:638-657.
5. Blom G. Statistical Estimates and Transformed Beta Variables 1958, J. Wiley and Sons, NY.
6. Clark, C.R., Schreiner, C.A., Parker, C.M., Gray, T., Hoffman, G., 2014. Health assessment of gasoline and fuel oxygenate vapors: subchronic inhalation toxicity. Regul. Toxicol. Pharmacol. 70 (2S), S18-S28. http://dx.doi.org/10.1016/j.yrtph.2014.07.003.
7. Franke H., Kittner H., Wirkner K., Schramek J. The reaction of astrocytes and neurons in the hippocampus of adult rats during chronic ethanol treatment and correlation with behavioral impairment. Alcohol 1997, 14(5):445-454.
8. Henley, M., Letinsky, D.J., Carr, J., Caro, M., Daughtrey, W., White, R., 2014. Health assessment of gasoline and fuel oxygenate vapors: generation and characterization of test materials. Regul. Toxicol. Pharmacol. 70 (2S), S13-S17. http://dx.doi.org/10.1016/j.yrtph.2014.05.012.
9. Keppel G. Design and Analysis: A Researcher's Handbook 1973, Prentice-Hall Inc., Engelwood Cliffs, NJ.
10. Martin P., O'Callaghan J. Biochemical immunohistology. Central Nervous System Trauma: Research Techniques 1995, 509-516. CRC Press, Baca Raton, FL. S.T. Ohnishi, T. Ohnishi (Eds.).
11. Meyer O.A., Tillson H.A., Byrd W.C., Riley M.T. A method for the routine assessment of fore- and hind-limb grip strength of rats and mice. Neurobehav. Toxicol. 1979, 1:233-236.
12. Moser V.C. Screening approaches to neurotoxicity: a functional observational battery. J. Am. Coll. Toxicol. 1989, 8(1):85-94.
13. Norton W.T., Aquino D.A., Hozumi I., Chiu F.-C., Brosnan C.F. Quantitative aspects of reactive gliosis: a review. Neurochem. Res. 1992, 17:877-885.
14. O'Callaghan J.P. Neurotypic and gliotypic proteins as biochemical markers of neurotoxicity. Neurotoxicol. Teratol. 1988, 10:445-452.
15. O'Callaghan J.P. Quantification of glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISA. Neurotoxicol. Teratol. 1991, 13:275-281.
16. O'Callaghan J.P. The use of glial fibrillary acidic protein in first-tier assessments of neurotoxicity. J. Am. Coll. Toxicol. 1991, 10(6):719-726.
17. O'Callaghan J.P. Measurement of glial fibrillary acidic protein. Current Protocols in Toxicology 2002, 12.8.1-12.8.12. John Wiley and Sons, New York. L.G. Costa (Ed.).
18. O'Callaghan J.P., Sriram K. GFAP and other glial proteins as biomarkers of neurotoxicity. Exp. Opin. Drug Saf. 2005, 4:433-442.
19. O'Callaghan, J.P., Kelly, K.A., Van Gilder, R.L., Sofroniew, M.V., Miller, D.B., 2014. Early activation of STAT3 regulates reactive astrogliosis induced by diverse forms of neurotoxicity. PlosOne (submitted for publication).
20. SAS Institute, Inc., 1995. JMP Statistics and Graphics Guide. Version 3.
21. Schreiner, C., Hoffman, G., Mason, C., Gudi, R., Clark, C.R., 2014. Health assessment of gasoline and fuel oxygenate vapors: micronucleus and sister chromatid exchange tests by inhalation exposure. Regul. Toxicol. Pharmacol. 70 (2S), S29-S34. http://dx.doi.org/10.1016/j.yrtpr.2014.05.014.
22. Schulze Gene E. Large-scale assessment of motor activity in rodents: procedures for routine use in toxicology studies. Journal of American College of Toxicology 1990, 9:455-463.
23. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenket D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150(1):76-85. 10.1016/0003-2697(85)90442-7.
24. US EPA, 1994a. GFAP Assay 79.67, CFR Vol. 59, No. 122, 27 June 1994.
25. US EPA, 1994b. Good Laboratory Practice Standards 79.60, CFR Vol. 59, No. 122, 27 June 1994.
26. US EPA, 1994c. GLP for Neuropathology Assessments 79.66, CFR Vol. 59, No. 122, 27 June 1994.
27. US EPA, 1998. OPPTS Health Effects Test Guidelines 870.6200, Neurotoxicity Screening Battery, August 1998.
28. White, K.L., Peachee, V.L., Armstrong, S. R., Twerdok, L.E., Clark, C.R., Schreiner, C.A., 2014. Health assessment of gasoline and fuel oxygenate vapors: immunotoxicity evaluation. Regul. Toxicol. Pharmacol. 70 (2S), S43-S47. http://dx.doi.org/10.1016/j.yrtph.2014.04.010.